Artios Pharma
Artios Pharma is a independent DNA Damage Response company with a strong pipeline of novel cancer therapies.
Artios Pharma is a business in biopharma, biotechnology, medical device based in Europe, Middle East, and Africa (EMEA), founded in 2016.
As a business in biopharma, biotechnology, medical device, Artios Pharma is listed here with the public details available about it.
The business is associated with Europe, Middle East, and Africa (EMEA).
The company is listed at the Series_C stage of development.
Recorded headcount: c_00011_00050 employees.
Public records show total funding of about $298.3M.
| Sector | Biopharma, Biotechnology, Medical Device |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2016 |
| Employees | c_00011_00050 |
| Stage | series_c |
| Total funding | $298,284,297 |
Website: www.artiospharma.com
Sign in to view the contact information we hold for Artios Pharma.
Create a free account
Create a free account